The Melanoma Research Alliance invites proposals for its young investigator awards. These support translational science in melanoma research.
Areas of specific interest are:
- identifying strategies to overcome resistance, treatment failure, or difficult-to-treat melanoma subtypes;
- informing logical and optimal combination therapies, therapeutic sequences, or treatment regimens;
- developing strategies to prevent or treat metastatic disease;
- identifying markers of response, resistance, or risk of recurrence or death;
- improving prevention and early detection strategies by understanding the biological basis for melanoma formation or developing new diagnostic approaches.
Funding & Duration
Awards are worth up to USD $75,000 (approx. AUD $102,000) each per year, for three years.
Primary Investigators (PIs) must be within four years of their first independent, with a full-time academic faculty appointment at the level of assistant professor or equivalent or above, at an academic or other non-profit research institution within or outside the US.
They must have a mentor who is an established investigator, based at the same institution.
Scientists employed by government agencies may serve as co-investigators or collaborators, but may not be PIs.
Submission Requirements & Due Dates
- 19 October 2018 – Applicant Eligibility Checklist due
- 26 October 2018 – full applications submitted for internal review
- Please email email@example.com if you are considering applying for this scheme
- See also: Submitting an Application to Research Services for Review